Navigate Questions About the Medicare GLP-1 Bridge
July 2026
You’ll see even more patients admitted on a GLP-1 agonist for obesity due to Medicare’s GLP-1 Bridge program launching July 1, 2026.
Plus many patients may be unaware of this new program. Be ready to answer questions from patients, prescribers, family and friends, etc.
What is the GLP-1 Bridge? It’s a program from Centers for Medicare & Medicaid Services (CMS) that allows eligible patients with Medicare Part D to get certain GLP-1 drugs for weight management for a $50 copay.
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote